Literature DB >> 30382934

New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis.

Stephen M Stahl.   

Abstract

More than a decade of failure to find disease-modifying treatments for Alzheimer's dementia has driven the field back to finding better symptomatic treatments for behavioral symptoms of dementia, especially psychosis and agitation.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30382934     DOI： 10.1017/S1092852918001360

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


  2 in total

1.  Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.

Authors:  D P Devanand; Elizabeth Crocco; Brent P Forester; Mustafa M Husain; Seonjoo Lee; Ipsit V Vahia; Howard Andrews; Laura Simon-Pearson; Nadia Imran; Luminita Luca; Edward D Huey; Deborah A Deliyannides; Gregory H Pelton
Journal:  Am J Geriatr Psychiatry       Date:  2021-05-12       Impact factor: 4.105

Review 2.  Therapy for Alzheimer's disease: Missing targets and functional markers?

Authors:  Milan Stoiljkovic; Tamas L Horvath; Mihály Hajós
Journal:  Ageing Res Rev       Date:  2021-03-09       Impact factor: 11.788
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.